Hwa Yeon Ko, PharmD

PhD student
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea, Republic of Korea

Hwa Yeon Ko received her PharmD at School of Pharmacy, Sungkyunkwan University in February 2022. She is currently a PhD student in the Department of Pharmacoepidemiology and Pharmacovigilance at the same institution. Her research interests include pharmacoepidemiology, with a particular focus on generating safety evidence for antidiabetic drugs in vulnerable populations and patients with chronic comorbidities.

Disclosure information not submitted.

Presentation(s):

• Risk of Facial Palsy Following COVID-19 Vaccination: A Nationwide Large-Linked Database Study

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• Dementia Associated With Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Emulating 6 Cardiovascular Outcome Trials of Antihyperglycemics in Patients with Type 2 Diabetes: A Multinational Analysis Based on 3 Asian Real-World Databases

  Tuesday, August 27, 2024
  1:40 PM – 1:45 PM CEST

• Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

  Wednesday, August 28, 2024
  2:15 PM – 2:30 PM CEST